Lorenzo Memeo

10.1k total citations · 4 hit papers
108 papers, 6.1k citations indexed

About

Lorenzo Memeo is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Lorenzo Memeo has authored 108 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 40 papers in Oncology and 22 papers in Surgery. Recurrent topics in Lorenzo Memeo's work include Cancer Cells and Metastasis (12 papers), Cancer-related Molecular Pathways (8 papers) and Neuroendocrine Tumor Research Advances (8 papers). Lorenzo Memeo is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Cancer-related Molecular Pathways (8 papers) and Neuroendocrine Tumor Research Advances (8 papers). Lorenzo Memeo collaborates with scholars based in Italy, United States and Montenegro. Lorenzo Memeo's co-authors include Hanina Hibshoosh, Mahesh Mansukhani, Ramon Parsons, Ruggero De Maria, Cristina Colarossi, Heidrun Rotterdam, Raffaella Giuffrida, Stefano Forte, Matthew Maurer and Lao H. Saal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Gastroenterology.

In The Last Decade

Lorenzo Memeo

105 papers receiving 6.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

2008 789 citations Raffaella Giuffrida, Lorenzo Memeo et al. profile →
PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma

2005 681 citations Lao H. Saal, Karolina Holm et al. Cancer Research profile →
Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth

2017 331 citations Giovanna Calabrese, Stefano Forte et al. profile →
SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection

2022 111 citations Cristina Colarossi, Lorenzo Memeo et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lorenzo Memeo	3.4k	1.9k	1.5k	1.1k	983	108	6.1k
Míriam Cuatrecasas	2.9k 0.8×	1.7k 0.9×	2.3k 1.5×	1.1k 1.0×	1.0k 1.1×	183	6.3k
Roberta Maestro	4.9k 1.4×	1.5k 0.8×	2.9k 1.9×	1.8k 1.6×	599 0.6×	121	8.5k
Satoshi Fujii	2.3k 0.7×	1.4k 0.7×	2.4k 1.6×	1.4k 1.3×	1.2k 1.3×	271	6.7k
Wolfgang Dietmaier	2.5k 0.7×	1.4k 0.7×	2.3k 1.5×	989 0.9×	1.4k 1.4×	135	6.2k
Francisco J. Vizoso	2.4k 0.7×	2.1k 1.1×	2.3k 1.5×	866 0.8×	1.0k 1.0×	199	6.5k
Giuseppe Pirozzi	2.0k 0.6×	787 0.4×	1.6k 1.1×	702 0.6×	1.1k 1.2×	94	5.7k
Marie‐Françoise Heymann	1.6k 0.5×	834 0.4×	1.6k 1.1×	1.2k 1.1×	866 0.9×	121	4.7k
Teiichi Motoyama	3.1k 0.9×	825 0.4×	1.1k 0.7×	935 0.9×	1.3k 1.3×	185	5.8k
Luigi Insabato	1.5k 0.4×	884 0.5×	996 0.7×	1.1k 1.0×	946 1.0×	222	5.6k
Edwin Choy	3.2k 0.9×	1.1k 0.6×	2.8k 1.9×	4.0k 3.7×	689 0.7×	203	8.5k

Countries citing papers authored by Lorenzo Memeo

Since Specialization

Citations

This map shows the geographic impact of Lorenzo Memeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Memeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Memeo more than expected).

Fields of papers citing papers by Lorenzo Memeo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Memeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Memeo. The network helps show where Lorenzo Memeo may publish in the future.

Co-authorship network of co-authors of Lorenzo Memeo

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Memeo. A scholar is included among the top collaborators of Lorenzo Memeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Memeo. Lorenzo Memeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raciti, Gabriele, Raffaella Giuffrida, Cristina Grange, et al.. (2025). Single-Vesicle Molecular Profiling by dSTORM Imaging in a Liquid Biopsy Assay Predicts Early Relapse in Colorectal Cancer. Biomolecules. 15(9). 1307–1307.

Angelico, Giuseppe, Lorenzo Colarossi, Cristina Colarossi, et al.. (2024). ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation. Cancers. 16(11). 2062–2062. 8 indexed citations

Sardo, Federica Lo, Stefano Scalera, Lorenzo Memeo, et al.. (2023). Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression. Cell Death and Disease. 14(1). 21–21. 46 indexed citations

Angelico, Giuseppe, Giuseppe Broggi, Lidia Puzzo, et al.. (2023). Tumor Infiltrating Lymphocytes (TILS) and PD-L1 Expression in Breast Cancer: A Review of Current Evidence and Prognostic Implications from Pathologist’s Perspective. Cancers. 15(18). 4479–4479. 28 indexed citations

Angelico, Giuseppe, Giuseppe Broggi, Lidia Puzzo, et al.. (2023). Immune Microenvironment and PD-L1 Expression in Breast Cancer: A Review of Current Evidence and Prognostic Implications from Pathologist’s Perspective. Preprints.org. 8 indexed citations

Angerilli, Valentina, Francesco Pepe, Gabriella Fontanini, et al.. (2023). The ideal reporting of RAS testing in colorectal adenocarcinoma: a pathologists’ perspective. Pathologica. 1–11. 3 indexed citations

Iacono, Melania Lo, Miriam Gaggianesi, Paola Bianca, et al.. (2022). Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy. Journal of Clinical Medicine. 11(23). 6996–6996. 10 indexed citations

Colarossi, Cristina, et al.. (2021). Clear Cell Carcinoma Arising in an Abdominal Wall Cesarean Section Scar: A Case Report With Description of Pathological and Molecular Features. Frontiers in Surgery. 8. 735381–735381. 4 indexed citations

Giuffrida, Dario, Raffaella Giuffrida, Ivana Puliafito, et al.. (2019). Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer. International Journal of Surgical Oncology. 2019. 1–7. 6 indexed citations

10.

Calabrese, Giovanna, Raffaella Giuffrida, Stefano Forte, et al.. (2017). Human adipose-derived mesenchymal stem cells seeded into a collagen-hydroxyapatite scaffold promote bone augmentation after implantation in the mouse. Scientific Reports. 7(1). 7110–7110. 61 indexed citations

11.

Giuffrida, Raffaella, Luana Adamo, Gioacchin Iannolo, et al.. (2016). Resistance of papillary thyroid cancer stem cells to chemotherapy. Oncology Letters. 12(1). 687–691. 29 indexed citations

12.

Ayyoub, Maha, Lorenzo Memeo, Emilio Álvarez‐Fernández, et al.. (2014). Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS. Cancer Immunology Research. 2(10). 943–948. 21 indexed citations

13.

Hamaï, Ahmed, Pascale Pignon, Isabelle Raimbaud, et al.. (2011). Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy. PLoS ONE. 6(6). e21129–e21129. 21 indexed citations

14.

Mordukhovich, Irina, Pavel Rössner, Mary Beth Terry, et al.. (2009). Associations between Polycyclic Aromatic Hydrocarbon–Related Exposures and p53 Mutations in Breast Tumors. Environmental Health Perspectives. 118(4). 511–518. 53 indexed citations

15.

Xia, Wei, Satoru Nagase, Sergey Kalachikov, et al.. (2008). BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer. Cancer Research. 68(6). 1667–1674. 124 indexed citations

16.

Rössner, Pavel, Marilie D. Gammon, Yu‐Jing Zhang, et al.. (2008). Mutations in p53, p53 protein overexpression and breast cancer survival. Journal of Cellular and Molecular Medicine. 13(9b). 3847–3857. 37 indexed citations

17.

Larghi, Alberto, Charles J. Lightdale, Andrew S. Ross, et al.. (2007). Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy. 39(12). 1086–1091. 119 indexed citations

18.

Memeo, Lorenzo, Jeffrey S. Jhang, Adel Assaad, et al.. (2007). Immunohistochemical Analysis for Cytokeratin 7, KIT, and PAX2. American Journal of Clinical Pathology. 127(2). 225–229. 59 indexed citations

19.

Saal, Lao H., Karolina Holm, Matthew Maurer, et al.. (2005). PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma. Cancer Research. 65(7). 2554–2559. 681 indexed citations breakdown →

20.

Pecorella, Irene, Antonio Ciardi, Lorenzo Memeo, et al.. (1999). Inflammatory Pseudotumour of the Liver — Evidence for Malignant Transformation. Pathology - Research and Practice. 195(2). 115–120. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact